PlateletP2Y12receptors are involved in the haemostatic effect of notoginsenosideFt1, a saponin isolated fromPanax notoginseng
Authors:
Open Access
- 4 October 2013
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 171 (1) , 214-223
Abstract
Background and Purpose: Saponins isolated fromPanax notoginseng(Burk.)F.H.Chen have been shown to relieve thrombogenesis and facilitate haemostasis. However, it is not known which saponin accounts for this haemostatic effect. Hence, in the present study we aimed to identify which saponins contribute to its haemostatic activity and to elucidate the possible underlying mechanisms.Experimental Approach: Platelet aggregation was analysed using a platelet aggregometer. Prothrombin time, activated partial thromboplastin time and thrombin time were measured using a blood coagulation analyser, which was further corroborated with bleeding time and thrombotic assays. The interaction of notoginsenosideFt1with the plateletP2Y12receptor was determined by molecular docking analysis, cytosolic Ca2+ andcAMPmeasurements, and phosphorylation ofPI3KandAktassays.Key Results: Among the saponins examined,Ft1was the most potent procoagulant and induced dose‐dependent platelet aggregation.Ft1reduced plasma coagulation indexes, decreased tail bleeding time and increased thrombogenesis. Moreover, it potentiatedADP‐induced platelet aggregation and increased cytosolic Ca2+ accumulation, effects that were attenuated by clopidogrel. Molecular docking analysis suggested thatFt1binds to plateletP2Y12receptors. The increase in intracellular Ca2+ evoked byFt1inHEK293cells overexpressingP2Y12receptors could be blocked by ticagrelor.Ft1also affected the production ofcAMPand increased phosphorylation ofPI3KandAktdownstream ofP2Y12signalling pathways.Conclusion and Implications: Ft1enhanced platelet aggregation by activating a signalling network mediated throughP2Y12receptors. These novel findings may contribute to the effective utilization of this compound in the therapy of haematological disorders.Keywords
This publication has 33 references indexed in Scilit:
- Ginsenoside‐Rp1 inhibits platelet activation and thrombus formation via impaired glycoprotein VI signalling pathway, tyrosine phosphorylation and MAPK activationBritish Journal of Pharmacology, 2012
- Guidelines for reporting experiments involving animals: the ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Mutational analysis of residues important for ligand interaction with the human P2Y12 receptorEuropean Journal of Pharmacology, 2010
- Ticagrelor binds to human P2Y12 independently from ADP but antagonizes ADP‐induced receptor signaling and platelet aggregationJournal of Thrombosis and Haemostasis, 2009
- Screening of anti‐platelet aggregation agents from Panax notoginseng using human platelet extraction and HPLC–DAD–ESI‐MS/MSJournal of Separation Science, 2008
- Pharmacological activity of sanchi ginseng (Panax notoginseng)Journal of Pharmacy and Pharmacology, 2006
- Developing a Small Animal Model of Extracorporeal CirculationASAIO Journal, 2006
- The role of ADP receptors in platelet functionFrontiers in Bioscience-Landmark, 2006
- Role of the Extracellular Loops of G Protein-Coupled Receptors in Ligand Recognition: A Molecular Modeling Study of the Human P2Y1ReceptorBiochemistry, 1999